Previous 10 | Next 10 |
2024-07-23 07:31:42 ET More on Merck Merck: Positive Developments, But Watch The Q2 Earnings Merck: Among The Best Health Care GARP Plays Today Merck & Co., Inc. (MRK) Goldman Sachs 45th Annual Global Healthcare Conference - (Transcript) Kamala Harris' po...
2024-07-21 21:02:13 ET More on health care stocks Elevance Health: Buy A Dividend Growth Machine Elevance extends losses as BofA cuts on Medicaid headwinds What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Merck: Among The Best Health Ca...
2024-07-21 08:01:00 ET More on related stocks: Visa Earnings: A Good Quarter Could Still Mean A Muted Share Price Response Danaher Q2: Inventory Overhang, But Low Expectations Limit Downside Why Truist Financial Stock Is Not A Buy Ahead Of Q2 Earnings Ford st...
2024-07-17 08:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, we’ll explore three stable blue-chip stocks to buy. As the earnings season approaches, Wall Street is getting readyfor potential market volatility. With the S&P...
2024-07-16 04:58:20 ET Summary Kymera Therapeutics is a protein degradation specialist drug developer with promising Phase 1 and 2 stage protein degraders targeting various diseases. A partnership with Sanofi includes potential milestone payments of up to $1.48 billion for IRAK4 p...
2024-07-13 10:10:44 ET More on CureVac BV, GSK, etc. Pfizer Opts To Move Forward With Once-Daily Danuglipron - Don't Hold Your Breath The Next Paxlovid Pfizer: Buy This Big Yielder On The Strong Pipeline Moderna rival CSPC cleared to study RSV shot in China ...
2024-07-11 08:33:24 ET More on GSK GSK plc: Long-Term Cash Cow GSK Breathes New Life Into Asthma Treatment With Depemokimab GSK plc (GSK) Q1 2024 Earnings Call Transcript GSK downgraded to Neutral at UBS GSk snaps six straight days of losses ...
2024-07-10 17:23:02 ET More on Sanofi Sanofi's Immunology Business Is Doing A Lot Of Heavy Lifting Sanofi: A Leader In Life-Saving Vaccines And Treatments Sanofi Q1: Wait And See For Now (Downgrade) Kymera announces expansion of KT-474 HS and AD phase 2 studi...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 10:32:15 ET Summary Ingrezza Sprinkle, granules, has been recently granted with the FDA approval. Supporting $2.1-2.2 billion in 2024 sales for the whole Ingrezza franchise guided by Neurocrine’s management. Neurocrine Biosciences, Inc. has two new drug applicati...
News, Short Squeeze, Breakout and More Instantly...
Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza Canada NewsWire TORONTO , July 26, 2024 /CNW/ - The National Advisory Committee on Immunization's (NACI) annual Statement...
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season Canada NewsWire TORONTO , July 25, 2024 /CNW/ - The Ontario Ministry of Health has announced a universal public program with Beyfortus ® (nirsevimab...